1.51
-0.05(-3.21%)
Currency In USD
| Previous Close | 1.56 |
| Open | 1.58 |
| Day High | 1.58 |
| Day Low | 1.5 |
| 52-Week High | 2.29 |
| 52-Week Low | 1.13 |
| Volume | 66,406 |
| Average Volume | 984,579 |
| Market Cap | 74.06M |
| PE | -6.04 |
| EPS | -0.25 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.38 |
| Change | -0.05 |
If you invested $1000 in MediciNova, Inc. (MNOV) 10 years ago, it would be worth $457.58 as of December 09, 2025 at a share price of $1.51. Whereas If you bought $1000 worth of MediciNova, Inc. (MNOV) shares 5 years ago, it would be worth $240.83 as of December 09, 2025 at a share price of $1.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code: 4875), today announced an update and the
Message from the CEO to MediciNova Shareholders
GlobeNewswire Inc.
Dec 01, 2025 11:00 PM GMT
Strengthening MN-001’s Scientific Foundation and Clinical OutlookLA JOLLA, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, Following the recent publication in the Journal of Atherosclerosis and Thrombosis, I would like to provi
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
GlobeNewswire Inc.
Nov 18, 2025 11:00 AM GMT
LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), is pleased to announce the a